CATALOGO DEI PRODOTTI DELLA RICERCA

VISCO, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.326
EU - Europa 6.970
AS - Asia 6.355
SA - Sud America 1.065
AF - Africa 263
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 22.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.143
RU - Federazione Russa 3.427
SG - Singapore 2.450
CN - Cina 1.829
BR - Brasile 795
GB - Regno Unito 784
VN - Vietnam 710
IT - Italia 640
HK - Hong Kong 579
FR - Francia 436
DE - Germania 427
IE - Irlanda 360
SE - Svezia 270
FI - Finlandia 191
KR - Corea 191
UA - Ucraina 134
IN - India 116
AR - Argentina 103
BD - Bangladesh 93
CA - Canada 81
NL - Olanda 63
NG - Nigeria 62
ID - Indonesia 60
MX - Messico 56
EC - Ecuador 55
JP - Giappone 45
BJ - Benin 44
ZA - Sudafrica 43
AT - Austria 42
TR - Turchia 42
CO - Colombia 41
IQ - Iraq 41
PL - Polonia 40
ES - Italia 31
AU - Australia 30
PK - Pakistan 29
TN - Tunisia 24
SA - Arabia Saudita 21
CL - Cile 20
BE - Belgio 19
MA - Marocco 18
UZ - Uzbekistan 17
VE - Venezuela 16
GR - Grecia 15
LT - Lituania 15
MY - Malesia 15
PH - Filippine 15
PT - Portogallo 15
TG - Togo 15
KE - Kenya 14
PY - Paraguay 13
CH - Svizzera 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
TH - Thailandia 10
IL - Israele 9
NP - Nepal 9
CR - Costa Rica 8
DO - Repubblica Dominicana 7
EU - Europa 7
OM - Oman 7
AL - Albania 6
BO - Bolivia 6
KG - Kirghizistan 6
NI - Nicaragua 6
RO - Romania 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
DK - Danimarca 5
ET - Etiopia 5
IR - Iran 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
QA - Qatar 5
AO - Angola 4
AZ - Azerbaigian 4
BG - Bulgaria 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
RS - Serbia 4
SY - Repubblica araba siriana 4
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
HR - Croazia 3
KH - Cambogia 3
LB - Libano 3
PA - Panama 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BY - Bielorussia 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
Totale 21.986
Salva come PNG Salva come JPEG
Città #
Singapore 1.284
Moscow 1.129
Ashburn 1.033
San Jose 959
Dallas 910
Southend 592
Hong Kong 573
Chandler 569
Jacksonville 562
Dublin 352
Beijing 348
The Dalles 310
Verona 298
Ho Chi Minh City 229
Munich 166
Hanoi 161
New York 154
Lawrence 152
Princeton 152
Wilmington 150
Los Angeles 142
Jinan 130
Woodbridge 113
Nanjing 111
Shenyang 110
Helsinki 109
Houston 86
São Paulo 84
Redondo Beach 83
Buffalo 80
Tianjin 76
Hebei 68
Council Bluffs 56
London 56
Abuja 48
Zhengzhou 47
Santa Clara 46
Cotonou 44
Orem 44
Sindelfingen 44
Taizhou 40
Tokyo 40
Changsha 39
Frankfurt am Main 39
Guangzhou 37
Jiaxing 37
Haikou 36
Ann Arbor 35
Columbus 35
Dearborn 35
Redmond 35
Jakarta 34
Milan 34
Grafing 33
Warsaw 33
Dong Ket 31
Hangzhou 31
Ningbo 31
Haiphong 30
Brooklyn 29
Montreal 28
Nanchang 28
Seattle 28
Taiyuan 27
Toronto 26
Turku 26
Chennai 25
Guayaquil 25
Rio de Janeiro 25
San Francisco 25
Lanzhou 24
Norwalk 24
Johannesburg 23
Chicago 22
Denver 22
Belo Horizonte 21
Boston 21
Nuremberg 21
Amsterdam 20
Redwood City 20
Vienna 20
Baghdad 19
Dhaka 19
Fuzhou 19
Mexico City 19
Stockholm 18
Washington 18
Atlanta 17
Da Nang 17
Salvador 17
Biên Hòa 16
Lappeenranta 16
Manchester 16
Melbourne 16
Mumbai 16
Seoul 16
Boardman 15
Hải Dương 15
Lomé 15
Phoenix 15
Totale 13.174
Salva come PNG Salva come JPEG
Nome #
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 215
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 213
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 211
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 202
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 196
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 191
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 188
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 187
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 181
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 179
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia 174
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 171
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 170
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 169
A prognostic model for patients with lymphoma and {COVID}-19: a multicentre cohort study 166
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma 165
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary? 164
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi 164
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 163
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 160
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 158
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 157
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma 157
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors 156
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 156
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 156
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 154
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 153
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis 152
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 152
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 151
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 150
Autoimmune cytopenias in chronic lymphocytic leukemia 150
B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities 148
Life-Threatening Protein-Losing Enteropathy Due To Human Cytomegalovirus Infection Upon Immunochemotherapy 148
Genetic and phenotypic attributes of splenic marginal zone lymphoma 147
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 146
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 146
Autoimmune haemolytic anaemia in mantle cell lymphoma : an insidious complication associated with leukemic disease 145
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma 144
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy 143
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 142
Bendamustine plus rituximab: is it a BRIGHT idea? 139
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 138
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 137
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 137
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi 137
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 137
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 136
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma 136
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi 134
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma 133
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 133
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 132
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 131
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases 130
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study 128
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and {CAR}-T Cell Therapy 128
The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia 127
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 122
Toxoplasma Gondii encephalitis in two allogeneic bone marrow transplant recipients: an emerging infection after heavy immunosoppressive therapy 122
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 121
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 121
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi. 120
High dose sequential chemotherapy (HDSC) as salvage therapy for patients with malignant lymphomas: prognostic factors and clinical outcomes 119
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. 119
A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma 119
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 119
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 118
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy 118
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study) 116
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 115
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study 114
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 113
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 112
Aggressive B-cell Lymphoma with {MYC}/{TP}53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents 112
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease 111
Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia 111
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study 110
Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment 110
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 109
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. 108
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 108
The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell lines 108
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium 107
Mantle cell lymphoma patients in first relapse: we pretty much know what to do 107
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma 105
Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status 105
T CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: CLINICO-PATHOLOGICAL FEATURES AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS 105
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 104
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 104
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study 102
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia 102
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia 102
Differential diagnosis of lymphocytosis in routine laboratory practice: the contribution of Sysmex- XN9100 101
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 101
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 101
Computerized drug management in a Bone Marrow Transplant Unit: towards an improvement of hospital drug management 100
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas 100
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy? 99
Totale 13.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.463
article - articoli 70.733
book - libri 0
conference - conferenze 4.730
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021212 0 0 0 0 0 0 0 0 0 20 139 53
2021/2022915 52 197 17 44 35 27 46 64 35 29 58 311
2022/20231.992 168 170 210 271 186 523 31 114 214 18 49 38
2023/20241.080 38 93 82 103 99 215 50 106 12 33 174 75
2024/20253.537 204 188 87 571 132 141 176 213 506 271 313 735
2025/202612.002 738 885 811 1.713 3.351 803 1.057 750 1.252 642 0 0
Totale 22.290